Promethazine Hydrochloride/Sulfogaiacol/Ammonium Chloride

盐酸异丙嗪/愈创木酚磺酸钾/氯化铵

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePromethazine Hydrochloride/Sulfogaiacol/Ammonium Chloride
Drug Alias Name复方愈创木酚磺酸钾口服溶液
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor agonistsMuscarinic acetylcholine receptor M1 antagonistsMuscarinic acetylcholine receptor M5 antagonists +[7] 
TargetsGlucocorticoid receptorMuscarinic acetylcholine receptor M2Muscarinic acetylcholine receptor M1 +[7] 
Therapy Area/IndicationsCommon Cold
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Promethazine HydrochlorideSulfogaiacolAmmonium Chloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeR01AD58
Related LinksN/A